Drug Target Modification
Drug Target Modification - Related Videos
11:56
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
0 Views •
Cited by 4 •
2013
Acquired resistance to antibiotics is a major public healthcare problem and is presently ranked by the WHO as one of the greatest threats to human life. Here we describe the use of cantilever technology to quantify antibacterial resistance, critical to the discovery of novel and powerful agents against multidrug resistant bacteria.
01:28
Hypertension IV: Drug Therapy and Lifestyle Modifications
0 Views •
2025
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
01:26
Targets for Drug Action: Overview
0 Views •
2023
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes. Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
09:48
Profiling of H3K4me3 Modification in Plants using Cleavage under Targets and Tagmentation
0 Views •
Cited by 1 •
2022
Cleavage under targets and tagmentation (CUT&Tag) is an efficient chromatin epigenomic profiling strategy. This protocol presents a refined CUT&Tag strategy for the profiling of histone modifications in plants.
01:29
Pharmacogenomics: Identification of New Drug Targets
0 Views •
2026
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
FAQs
The resulting drug response depends on which molecular feature changes. Altering a protein sequence can reshape the binding site and drug affinity, whereas changing expression levels can alter target abundance. Modifying a post-translational state may instead influence signaling. Comparing these outcomes helps connect a specific molecular alteration with the pharmacological behavior observed.
Target abundance and binding-site properties influence drug action in different ways. More or less target protein can change how much drug-responsive material is present, while a sequence change may alter how well the drug binds. Examining both dimensions prevents researchers from attributing every response change to altered affinity alone and clarifies the mechanism under study.
Drug Target Modification can reveal why a treatment loses effectiveness or affects unintended biology. A change near the binding site may reduce drug affinity and support a resistance mechanism, while alterations affecting signaling can change the downstream response without directly changing binding. These comparisons also help evaluate whether a target can be influenced selectively.
Researchers select a target gene, protein sequence, expression level, or post-translational state to alter, then examine the resulting response to the drug in cultured cells or an experimental organism. The comparison links the molecular change with binding, target abundance, signaling, or pharmacological outcome, providing a structured way to test target function.
Results are interpreted by asking whether the alteration changes drug affinity, target abundance, signaling, or the overall pharmacological response. A consistent link between the molecular change and altered drug behavior can support target validation, whereas differing effects across modifications can indicate that several target properties contribute to activity or resistance.
It supports several stages of biological and therapeutic research. In target validation, deliberate changes test whether a molecule or pathway contributes to drug action. In resistance studies, they help identify alterations associated with reduced effectiveness. Researchers can also use modified cultured cells or experimental organisms to model selectivity and patient-specific responses, supporting development of more effective treatments.